BioCryst Pharmaceuticals, Inc. (BCRX)
9.58
+0.18
(+1.91%)
USD |
NASDAQ |
Mar 26, 12:08
BioCryst Pharmaceuticals Free Cash Flow : 327.41M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Anika Therapeutics, Inc. | 4.362M |
| Lantheus Holdings, Inc. | 348.64M |
| Revolution Medicines, Inc. | -913.73M |
| Plus Therapeutics, Inc. | -20.84M |
| BioStem Technologies, Inc. | 12.23M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 276.04M |
| Cash from Investing (Quarterly) | -83.49M |
| Cash from Financing (Quarterly) | -202.04M |
| Free Cash Flow Per Share (Quarterly) | 1.255 |
| Free Cash Flow to Equity (Quarterly) | 481.01M |
| Free Cash Flow to Firm (Quarterly) | 289.25M |
| Free Cash Flow Yield | 15.64% |